DeepMind releases AlphaGenome 2 to predict cell-type‑specific effects of genetic variants
DeepMind unveiled AlphaGenome 2, a successor to AlphaGenome that predicts how DNA variants affect specific cell types and states. Trained on over 100 million single-cell profiles across 68 tissues, the model reportedly detects nearly twice as many expression-altering variants as the prior state of the art and is being made available for non-commercial research via the AlphaGenome API with a limited private preview for commercial use.